Biotechnology Stocks
Notizie Biotechnology Stocks
BofA conferma il rating su Beam Therapeutics dopo il lodo arbitrale
Perché il titolo Beam Therapeutics sta scendendo oggi?
Perché il titolo Prime Medicine è in forte rialzo oggi?
Il titolo di Incyte raggiunge il massimo di 52 settimane a 118,77 USD
Il titolo di Prime Medicine sale dopo la vittoria nell’arbitrato contro Beam
Nurix Therapeutics: focus sull’impatto dell’accordo con Roche
Il titolo azionario di Edgewise Therapeutics raggiunge il massimo storico a 43,96 USD
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
VANI Vivani Medical, Inc. - Common Stock | 1.50 | +11.11% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
CCCC C4 Therapeutics, Inc. - Common Stock | 3.81 | -12.41% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |